RETRACTED: Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.

Safarinejad MR.

Open source

DOI
10.1111/j.1743-6109.2007.00698.x
Published
2007-12-28
Container
J Sex Med
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/j.1743-6109.2007.00698.x,
  title = {RETRACTED: Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.},
  author = {Safarinejad MR.},
  year = {2008},
  journal = {J Sex Med},
  doi = {10.1111/j.1743-6109.2007.00698.x},
  url = {https://doi.org/10.1111/j.1743-6109.2007.00698.x}
}

RIS

TY  - JOUR
TI  - RETRACTED: Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.
AU  - Safarinejad MR.
PY  - 2008
JO  - J Sex Med
DO  - 10.1111/j.1743-6109.2007.00698.x
UR  - https://doi.org/10.1111/j.1743-6109.2007.00698.x
ER  - 

APA

MR., S. (2008). RETRACTED: Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study.. J Sex Med. https://doi.org/10.1111/j.1743-6109.2007.00698.x

Source records